Last $68.41 USD
Change Today +0.59 / 0.87%
Volume 1.4M
DVA On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 04/15/14 All times are local (Market data is delayed by at least 15 minutes).

davita healthcare partners i (DVA) Key Developments

Independence Blue Cross and DaVita Healthcare Partners Announce Joint Venture

Independence Blue Cross and DaVita HealthCare Partners announced the creation of Tandigm Health. This unique joint venture, based in Philadelphia, Pa., will help deliver high-quality, affordable care to the region by combining the expertise of one of the country's largest, most innovative Blue insurers and a nationally recognized pioneer of physician-centric coordinated care.

Davita Healthcare Partners Inc. Announces Executive Changes

DaVita HealthCare Partners Inc. has announced that Javier Rodriguez will move from president to CEO of the company's kidney care division. Kent thiry will remain CEO of the company as well as co-chairman of the board of directors.

Davita HealthCare Partners Inc. Announces Executive Changes

On March 14, 2014, Dennis Kogod, Chief Operating Officer of DaVita HealthCare Partners Inc., transitioned out of his role as the company's Chief Operating Officer and fully transitioned into his role as Chief Operating Officer of the HealthCare Partners division of the company. On March 14, 2014, Javier Rodriguez, the company's President, transitioned out of his role as the company's President and into his new role as Chief Executive Officer of the company's dialysis and related lab services business.

DaVita to Treat Thousands in Saudi Arabia

DaVita, a division of DaVita HealthCare Partners Inc. announced it has signed a major tender from the Kingdom of Saudi Arabia's Ministry of Health to treat half of the approximately 10,000 dialysis patients currently under the Ministry's care. Under the award DaVita will operate as many as 80 centers and is undertaking a substantial recruitment effort to attract new clinical and administrative teammates from within Saudi Arabia and across the world. DaVita will also be a prime resource to the Ministry of Health in identifying ways to prevent kidney disease within the Kingdom of Saudi Arabia.

DaVita HealthCare Partners Reaches $389 Million Settlement with Government

DaVita HealthCare Partners Inc. is finalizing a $389 million criminal and civil settlement agreement with the federal government concerning a 2010 anti-kickback investigation into its joint venture agreements. The company noted that when completed, the settlement would end a four-year investigation by the Denver U.S. Attorney’s office, the U.S. Department of Justice and the U.S. Department of Health and Human Services. The company also noted it will also enter into a corporate integrity agreement, appoint an independence compliance monitor and impose certain business restriction on its joint venture arrangements with nephrologists. Federal prosecutors have alleged that medical centers in several of DaVita’s joint ownership ventures in were sold to Denver nephrologists at prices grossly below market value to ensure that the doctors’ kidney patients were directed to the DaVita-owned facilities.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVA:US $68.41 USD +0.59

DVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Labs Inc $27.23 USD -0.18
Fresenius Medical Care AG & Co KGaA €48.76 EUR +0.13
Genomic Health Inc $27.41 USD +0.94
Laboratory Corp of America Holdings $101.56 USD +0.81
Myriad Genetics Inc $38.75 USD +0.64
View Industry Companies
 

Industry Analysis

DVA

Industry Average

Valuation DVA Industry Range
Price/Earnings 23.5x
Price/Sales 1.2x
Price/Book 3.3x
Price/Cash Flow 12.4x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAVITA HEALTHCARE PARTNERS I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.